News | August 08, 2021
Abbott India net profit rises to 8.5 per cent in Q1FY22
PAT rises to Rs 195.76 crore
PAT rises to Rs 195.76 crore
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Innovative solutions and a deep understanding of the market makes this a unique combination
Arch Pharma Labs has filed the application
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
The company has reported total income of Rs.45.29 crores during the 12 months period ended March 31, 2021
India is expecting to manufacture 30-35 crore COVID-19 vaccines between July - August 2021
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Subscribe To Our Newsletter & Stay Updated
